BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17518775)

  • 1. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
    Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
    J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p63 in cutaneous metastases.
    Kanitakis J; Chouvet B
    Am J Clin Pathol; 2007 Nov; 128(5):753-8. PubMed ID: 17951196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
    Plaza JA; Ortega PF; Stockman DL; Suster S
    J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
    Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
    Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.
    Levy G; Finkelstein A; McNiff JM
    J Cutan Pathol; 2010 Apr; 37(4):411-5. PubMed ID: 19788442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin.
    Ivan D; Hafeez Diwan A; Prieto VG
    Mod Pathol; 2005 Jan; 18(1):137-42. PubMed ID: 15389254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p63 normal canine skin and primary cutaneous glandular carcinomas.
    Saraiva AL; Gärtner F; Pires MA
    Vet J; 2008 Jul; 177(1):136-40. PubMed ID: 17804265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
    Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
    Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin.
    Mahalingam M; Nguyen LP; Richards JE; Muzikansky A; Hoang MP
    Mod Pathol; 2010 May; 23(5):713-9. PubMed ID: 20190734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of p63 detection for differentiating primary from metastatic skin adenocarcinomas.
    Ivan D; Diwan AH; Lazar AJ; Prieto VG
    J Cutan Pathol; 2008 Sep; 35(9):880-1. PubMed ID: 18796086
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center.
    Sariya D; Ruth K; Adams-McDonnell R; Cusack C; Xu X; Elenitsas R; Seykora J; Pasha T; Zhang P; Baldassano M; Lessin SR; Wu H
    Arch Dermatol; 2007 May; 143(5):613-20. PubMed ID: 17515511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall.
    Cangelosi JJ; Nash JW; Prieto VG; Ivan D
    Am J Dermatopathol; 2009 May; 31(3):278-81. PubMed ID: 19384070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
    Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
    J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
    Thamboo TP; Tan LH; Tan SY
    J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
    Cao D; Ji H; Ronnett BM
    Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
    Kaufmann O; Fietze E; Mengs J; Dietel M
    Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
    Owens SR; Greenson JK
    Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.